Clinical Trials Logo

Hypoglycemia clinical trials

View clinical trials related to Hypoglycemia.

Filter by:

NCT ID: NCT04869709 Not yet recruiting - Prematurity Clinical Trials

Late Preterm Corticosteroids and Neonatal Hypoglycemia

Start date: July 2021
Phase: Phase 4
Study type: Interventional

This is a prospective randomized controlled trial investigating the timing of betamethasone administration in late preterm infants in relation to delivery and impact on neonatal hypoglycemia. Previous data has shown that neonatal hypoglycemia is increased in late preterm infants that were exposed to antenatal corticosteroids. The investigators hypothesize that the timing of steroid administration may impact the development of neonatal hypoglycemia.

NCT ID: NCT04811612 Not yet recruiting - Clinical trials for Neonatal Hypoglycemia

Comparing Heel Stick Glucoses in Neonates

CHECK IN
Start date: May 2021
Phase: N/A
Study type: Interventional

Newborn babies can develop low blood sugar (glucose) which can lead to brain injury and poor developmental outcomes. Therefore, it is important to accurately measure the blood glucose in babies. One way to measure the blood glucose is to test blood from the baby's heel with a bedside device called a point of care glucometer. This method is very common and easy; however, multiple factors can lead to an inaccurate reading. A false low reading may require additional blood testing and admission to the NICU. A false high reading could result in the medical provider missing the diagnosis of low blood glucose. Our team wants to know if there is a difference between blood glucose measurements taken from warmed and un-warmed heels of infants. Blood flow farther away from the heart, such as in the feet and heels, may be less than the rest of the body, and might move more slowly. This could cause the glucose level to be lower in the feet and heels. Therefore, sampling blood from an un-warmed heel may result in a falsely low glucose reading. There is some research that suggests warming the heel increases blood flow to the area; however, only one study that we know of has evaluated differences in blood glucose readings from warmed and un-warmed heels. They found significantly higher blood glucose readings from warmed heels compared to un-warmed heels in 57 babies. However, these babies were part of a larger study comparing different diets on blood glucose levels, and the heels were warmed using warm water which is no longer a current practice. The goal of this study is to compare the capillary blood glucose levels from warmed and un-warmed heels in about 100 infants who are breast and/or formula fed using the current practice of warming heels with gel heat packs. The null hypothesis is that there will be no difference between capillary blood glucose levels sampled from an infants warmed and un-warmed heel. The alternative hypothesis is that capillary blood glucose levels sampled from warmed heels will be higher than those samples from un-warmed heels.

NCT ID: NCT04595383 Not yet recruiting - Hypoglycemia Clinical Trials

Electronic Platform for Diabetic Patients Activation

INSULINCOM
Start date: October 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy of an electronic platform for doctor-patient communication in order to reduce severe and non-severe hypoglycemia events as well as inadvertent hypoglycemia events.

NCT ID: NCT04172116 Not yet recruiting - Hypoglycemia Clinical Trials

Continuous Glucose Monitoring (CGM) After Surgical Variations of the Roux-en-y Gastric Bypass

Start date: January 2020
Phase:
Study type: Observational

This study evaluates the difference in post prandial tissue glucose levels between two variation of Roux-en-Y Gastric bypass by continuous glucose monitoring.

NCT ID: NCT03702959 Not yet recruiting - Hypoglycemia Clinical Trials

Antenatal Betamethasone and the Risk of Neonatal Hypoglycemia

Start date: October 1, 2018
Phase:
Study type: Observational [Patient Registry]

A single "supraphysiological" course of exogenous corticosteroids is recommended between 24-34 weeks' gestation to minimize the adverse sequelae associated with prematurity. The 24-hour profile of endogenous corticosteroids normally follows a diurnal rhythm with the highest serum level occurs between 5am-11am and nadir over 12 hours.

NCT ID: NCT03448965 Not yet recruiting - Hyperglycemia Clinical Trials

Hypoglycemic and Hyperglycemic Disorders

Start date: December 15, 2018
Phase: N/A
Study type: Observational

Definition of low birth weight: Low birth weight infants are those born weighing less than 2500 g. These are further subdivided into: - Very Low Birth Weight : Birth weight <1,500 g - Extremely Low Birth Weight : Birth weight <1,000 g Their survival is directly related to birth weight, with approximately 20% of those between 500 and 600 g and>90% of those between 1,250 and 1,500 g surviving. Perinatalcare has improved the rate of survival of low birth weight infants.

NCT ID: NCT02909881 Not yet recruiting - Hypoglycemia Clinical Trials

Dose Response Oxidation of a Sweet-corn Derived Sugar (PhytoSpherix) During Exercise in Endurance Trained Athletes

Start date: September 2016
Phase: N/A
Study type: Interventional

PhytoSpherix (Phx) is an all-natural, edible polysaccharide extracted from sweet corn. This carbohydrate is the major muscle fuel for intense exercise and its stores are quite small such that one can run out of it during a single exercise bout. Therefore, Phx should provide significant exercise fuel if consumed during exercise. As a result its intake could enhance intense exercise performance by providing additional fuel. This experiment Will investigate the effects of 4 different dosages of Phx consumed throughout a prolonged exercise bout on carbohydrate and fat utilization as well as its oxidation rate and perception of effort during prolonged intense exercise in trained cyclists. Muscle and liver carbohydrate stores will be examined using a non-invasive ultrasound technique.

NCT ID: NCT02838875 Not yet recruiting - Clinical trials for Neonatal Hypoglycemia

To Examine if the Mother's Glucose Levels and Glucose Levels in the Blood Can Predict Cord Hypoglycemia in Newborns at Risk.

Start date: August 2016
Phase: Phase 3
Study type: Interventional

Background Neonatal hypoglycemia is one of the most common metabolic disorders in neonatology. Maintaining stable levels of glucose in the transition from fetal life to life after birth is very important. Yet, except for the recognizing of at-risk populations, there are not many individual measures which can help and predict which newborns (from at-risk populations) will develop hypoglycemia and which will not. OBJECTIVE our objective is to try to characterize by the mother's glucose levels at birth and by umbilical cord glucose levels who would be at increased risk of hypoglycemia in the hours after birth in the population that is at increased risk of this complication in advance.

NCT ID: NCT02648555 Not yet recruiting - Lifestyle Clinical Trials

A Lifestyle Intervention to Improve in Vitro Fertilization Results

W+D
Start date: May 2016
Phase: N/A
Study type: Interventional

Embryo adhesion and placentation depend on tissue plasminogen activator (tPA)-mediated activation of brain-derived neurotrophic factor, vascular endothelial growth factor and other growth factors, formation of hemidesmosomes, and degradation of extracellular matrix and basement membrane, either directly or by activating matrix metalloproteinases. Since glucose and insulin stimulate release of a major tPA inhibitor by endothelial cells - plasminogen activator inhibitor (PAI)-1 - the investigators hypothesized that lifestyle interventions proven effective in maintaining glucose and insulin levels within the normal range would increase the take home baby rate in women undergoing assisted reproduction.

NCT ID: NCT02586831 Not yet recruiting - Diabetes Mellitus Clinical Trials

Diabetes Islet Preservation Immune Treatment

DIPIT
Start date: June 1, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

To assess whether there is a difference in endogenous insulin secretion, measured as stimulated C-peptide secretion (area under the curve during a 4-hour mixed meal tolerance test), at the 1 year visit, for study subjects receiving combinational therapy versus those receiving placebo. The study will also examine the effect of the proposed treatments on immunological outcomes, specifically proportion of regulatory T cells at the 1 year visit.